Search the collection

58 results for Androgen+receptor-targeted+agent

Sort by:

Sort by

Limit results to:

20 per page

58 results for Androgen+receptor-targeted+agent

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an...
Author / Creator:Morgans, Alicia K. ; Hutson, Thomas ; Guan, Alice Kai Dan ; Garcia, David ; Zhou, Anna ; Drea, Edward ; Vogelzang, Nicholas J.
Publisher:London: BioMed Central
Journal title:BMC health services research, 2022-07, Vol.22 (1), p.1-916, Article 916
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort
Author / Creator:Ferriero, Mariaconsiglia ; Mastroianni, Riccardo ; De Nunzio, Cosimo ; Cindolo, Luca ; Calabrò, Fabio ; Tema, Giorgia ; Leonardo, Costantino ; Flammia, Rocco Simone ; Tuderti, Gabriele ; Anceschi, Umberto ; Brassetti, Aldo ; Giacinti, Silvana ; Guaglianone, Salvatore ; Ghahhari, Jamil ; Schips, Luigi ; Tubaro, Andrea ; Gallucci, Michele ; Simone, Giuseppe
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:World journal of urology, 2020-07, Vol.38 (7), p.1757-1764
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesFull Text
Dana-Farber Cancer Institute Researchers Add New Study Findings to Research in Prostate Cancer [An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patien...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2022-08, p.718
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
Newsletter articlesFull Text
New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer: CA...
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
Newsletter articlesFull Text
Press Release: Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become...
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
Newsletter articlesFull Text
Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to E...
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
Newsletter articlesFull Text
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate c...
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
Newsletter articlesFull Text
Press Release: New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant pr...
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
Newsletter articlesFull Text
Press Release: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-res...
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
Press Release: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-res...
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2019
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
Newspaper ArticlesFull Text
New England Journal of Medicine publishes data showing improved survival with Jevtana over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2019-09-30
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Chemotherapie ± Androgenrezeptorantagonisten beim metastasierten hormonsensitiven Prostatakarzinom
Author / Creator:Wenzel, Mike ; Hoeh, Benedikt ; Chun, Felix K. H ; Mandel, Philipp
Publisher:Heidelberg: Springer Nature B.V
Journal title:Urologe. Ausgabe A, 2023-04, Vol.62 (4), p.360-368
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer
Author / Creator:Murgić, Jure ; Fröbe, Ana ; Challapalli, Amarnath ; Bahl, Amit
Publisher:Croatia: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
Journal title:Acta clinica Croatica (Tisak), 2022-10, Vol.61 (Suppl 3), p.51-56
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Androgen receptor-targeted agents in the management of advanced prostate cancer
Author / Creator:Tombal, Bertrand
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2019-12, Vol.20 (12), p.1628-1630
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial...
Author / Creator:Francolini, Giulio ; Loi, Mauro ; Ciccone, Lucia Pia ; Detti, Beatrice ; Di Cataldo, Vanessa ; Pinzani, Pamela ; Salvianti, Francesca ; Salvatore, Giulia ; Sottili, Mariangela ; Santini, Costanza ; Frosini, Giulio ; Visani, Luca ; Burchini, Luca ; Mattioli, Chiara ; Allegra, Andrea Gaetano ; Valzano, Marianna ; Cerbai, Cecilia ; Aquilano, Michele ; Salvestrini, Viola ; Desideri, Isacco ; Mangoni, Monica ; Meattini, Icro ; Livi, Lorenzo
Publisher:New York: Springer US
Journal title:Medical oncology (Northwood, London, England), 2022-06, Vol.39 (8), p.119-119, Article 119
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER/ULOGA MODERNE ANTI-ANDROGENE TERAPIJE U LIJECENJU LOKALIZIRANOG RAKA PROSTATE
Author / Creator:Murgic, Jure ; Frobe, Ana ; Challapalli, Amarnath ; Bahl, Amit
Publisher:Klinicki bolnicki centar Sestre milosrdnice
Journal title:Acta clinica Croatica (Tisak), 2022-12, Vol.61 (S3), p.51
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
Author / Creator:Roberto, Michela ; Di Civita, Mattia Alberto ; Marinelli, Daniele ; Torchia, Andrea ; Cara, Nertila ; Maltese, Giulia ; Speranza, Iolanda ; Santini, Daniele
Publisher:United States: John Wiley & Sons, Inc
Journal title:BJUI compass, 2025-01, Vol.6 (1), p.e455-n/a
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesFull Text
Therapie des metastasierten Prostatakarzinoms im Wandel – neue Daten und offene Fragen
Author / Creator:Albers, P. ; Bögemann, M. ; Machtens, S. ; Merseburger, A. S. ; Schostak, M. ; Steuber, T. ; Wülfing, C. ; De Santis, M.
Publisher:Heidelberg: Springer Medizin
Journal title:Urologe. Ausgabe A, 2020-03, Vol.59 (3), p.307-317
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesFull Text
Fortgeschrittenes Prostatakarzinom: Sequenz aus androgenrezeptorgerichteten Substanzen und Chemotherapie entscheidet über das Langzeitüberleben
Author / Creator:Wülfing, Christian ; Goebell, Peter J. ; Eichenauer, Rolf ; Lange, Carsten ; Machtens, Stefan ; Schwentner, Christian ; Todenhöfer, Tilman ; Tauber, Robert ; Schostak, Martin
Publisher:Heidelberg: Springer Medizin
Journal title:Urologe. Ausgabe A, 2021-02, Vol.60 (2), p.212-221
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
Author / Creator:Rans, Kato ; Charlien, Berghen ; Filip, Ameye ; Olivier, De Hertogh ; Julie, den Hartog ; Céderic, Draulans ; Herlinde, Dumez ; Benedikt, Engels ; Karolien, Goffin ; Annouschka, Laenen ; Nick, Liefhooghe ; Kenneth, Poels ; Carl, Salembier ; Koen, Slabbaert ; Hans, Vandendriessche ; Ben, Vanneste ; Steven, Joniau ; Gert, De Meerleer
Publisher:England: BioMed Central Ltd
Journal title:BMC cancer, 2022-12, Vol.22 (1), p.1294-1294, Article 1294
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 58 results

Export record to excel

Export this record

Export record to excel

An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an...

Export this record

Export record to excel

Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort

Export this record

Export record to excel

Dana-Farber Cancer Institute Researchers Add New Study Findings to Research in Prostate Cancer [An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patien...

Export this record

Export record to excel

New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer: CA...

Export this record

Export record to excel

Press Release: Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become...

Export this record

Export record to excel

Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to E...

Export this record

Export record to excel

Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate c...

Export this record

Export record to excel

Press Release: New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant pr...

Export this record

Export record to excel

Press Release: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-res...

Export this record

Export record to excel

Press Release: Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana(R) (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-res...

Export this record

Export record to excel

New England Journal of Medicine publishes data showing improved survival with Jevtana over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

Export this record

Export record to excel

Chemotherapie ± Androgenrezeptorantagonisten beim metastasierten hormonsensitiven Prostatakarzinom

Export this record

Export record to excel

Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer

Export this record

Export record to excel

Androgen receptor-targeted agents in the management of advanced prostate cancer

Export this record

Export record to excel

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial...

Export this record

Export record to excel

ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER/ULOGA MODERNE ANTI-ANDROGENE TERAPIJE U LIJECENJU LOKALIZIRANOG RAKA PROSTATE

Export this record

Export record to excel

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis

Export this record

Export record to excel

Therapie des metastasierten Prostatakarzinoms im Wandel – neue Daten und offene Fragen

Export this record

Export record to excel

Fortgeschrittenes Prostatakarzinom: Sequenz aus androgenrezeptorgerichteten Substanzen und Chemotherapie entscheidet über das Langzeitüberleben

Export this record

Export record to excel

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?

Refine your search

Chemotherapie ± Androgenrezeptorantagonisten beim metastasierten hormonsensitiven Prostatakarzinom